The National Institute for Prevention and Cardiovascular Health (NIPC), has won the Research Paper of the Year Award at the 2020 Irish Healthcare Awards for the second year in a row! This paper was written by Professor Bill McEvoy, Medical and Research Director at NIPC on the Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes.
The objective of this paper was “To compare the prevalence of IDH in the United States, by 2017 ACC/AHA and 2003 Joint National Committee (JNC7) definitions, and to characterize cross-sectional and longitudinal associations of IDH with outcomes.”
NIPC was awarded the winning research paper for the JAMA-published medical paper challenging recent guidelines defining high blood pressure. The NIPC and NUI Galway investigation, led by Prof J William McEvoy, Medical and Research Director of the NIPC, called into question the validity of recent changes to treatment recommendations for a certain type of blood pressure patient, highlighting that up to 150,000 Irish patients may not need this additional treatment.
Announced on December 1, the Irish Healthcare Awards recognise innovation and excellence in the Irish healthcare sector and are Ireland’s leading Awards, now in their 19th year. Speaking about the awards, Neil Johnson, NIPC & Croí CEO, said: “We are delighted to win this award for the second year in a row! It’s great recognition for Irish cardiovascular disease prevention and the important work being undertaken at NIPC and NUI Galway.”
This award adds to NIPC’s winning streak at the Irish Healthcare Awards – in 2019, Croí and NIPC scooped three top awards.
The Irish Healthcare Awards is the leading medical awards ceremony in Ireland. This award ceromony was created by The Irish Medical Times. Due to Covid-19, the ceremony was made virtual for the first time. The entire ceromony can be watched on demand here.
If you would like to stay up to date with everything happening at the NIPC sign up to the NIPC Alliance now or subscribe to our newsletter below.
Recent Comments